When blood cancer starts to spread, tumor cells diversify and affect immune response
When blood cancer cells break through the bone and multiply, tumor cells become dangerously diverse and the immune response ...
Carsgen's First Enrolled Subject In The THANK-U Plustm Platform-Based Allogeneic CAR-T Trial Achieves Scr At Week 4
CARsgen Therapeutics Holdings Limited (Stock Code: 2171), a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors, announces that the first ...
CARsgen's First Enrolled Subject in the THANK-u Plus™ Platform-Based Allogeneic CAR-T Trial Achieves sCR at Week 4
CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on innovative CAR T-cell therapies for the ...
The American Journal of Managed Care3d
Prolonged Survival in MM: Insights from the Largest Ongoing US Registry
The Connect MM Registry is the longest-running and largest registry in the US, providing invaluable prognostic insights into ...
Pharmaceutical Technology3d
Dr Reddy’s and Shanghai Henlius sign agreement for HLX15
Dr Reddy's Laboratories has signed a licence agreement with Shanghai Henlius Biotech to develop and commercialise HLX15.
Daily3d
Dr Reddy's Labs inks pact with Henlius for commercialization of multiple myeloma injection HLX15 in US, Europe
Hyderabad: Dr Reddy's Laboratories SA, a wholly-owned subsidiary of Dr. Reddy's Laboratories Ltd. has announced that it has ...
Rare bone marrow transplant patient completed at Baton Rouge hospital
Our Lady of the Lake Cancer Institute is celebrating after successfully completing a bone marrow transplant so rare it has ...
Dr. Reddy’s in licenses biosimilar for J&J’s multiple myeloma therapy
Dr. Reddy's (RDY) partners with Shanghai Henlius Biotech to develop and market biosimilar versions of J&J's (JNJ) multiple ...
Business Wire4d
2seventy bio Reports Preliminary* Full-Year U.S. Abecma Sales and Select Financial Results
Inc. (Nasdaq: TSVT) today provided full-year Abecma® (idecabtagene vicleucel; ide-cel) sales results for 2024, in partnership with Brist ...